Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06458712
- Conditions
- Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency), Anophthalmia with pulmonary hypoplasia, Fanconi Anemia, Complementation Group D1, +1 more
- Locations
-
- Yale Cancer Center - Yale New Haven Hospital New Haven, Connecticut, United States
- Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York, United States
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
- Institut Bergonie Bordeaux, France
NCT04038502
- Conditions
- BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +23 more
- Locations
-
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States
- Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States
- Washington DC VA Medical Center, Washington, DC Washington D.C., District of Columbia, United States
- Bay Pines VA Healthcare System, Pay Pines, FL Bay Pines, Florida, United States
NCT00753545
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Research Site Berkeley, California, United States
- Research Site San Francisco, California, United States
- Research Site West Hollywood, California, United States
- Research Site Sunrise, Florida, United States
NCT00494234
- Conditions
- Breast Diseases, Breast Neoplasms, Fanconi Anemia, Complementation Group D1, +4 more
- Locations
-
- Research Site West Hollywood, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Melbourne, Australia
- Research Site Randwick, Australia
NCT00858078
- Conditions
- BRCA1 Gene, BRCA2 Gene, Fanconi Anemia, Complementation Group D1
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
NCT00438906
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +20 more
- Locations
-
- Johns Hopkins Hospital Baltimore, Maryland, United States
NCT00001806
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
- Locations
-
- Walter Reed National Medical Center Bethesda, Maryland, United States
NCT00628251
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
- Research Site Boca Raton, Florida, United States
- Research Site Boston, Massachusetts, United States
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
NCT01286987
- Conditions
- Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
- (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States
NCT00494442
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
NCT00419510
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT01346761
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +25 more
- Locations
-
- Huntsman Cancer Institute Salt Lake City, Utah, United States
NCT00776958
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
- Locations
-
- University of Alabama, Birmingham/Department of OB/GYN Birmingham, Alabama, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- NYU Cancer Institute New York, United States
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00677079
- Conditions
- Advanced Epithelial Ovarian Cancer, Fanconi Anemia, Complementation Group D1, Primary Peritoneal Cancer
- Locations
-
- New York, United States
NCT00165152
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
FaCT Trial (Facilitated Cascade Testing Trial)
NCT04613440
- Conditions
- BRCA1 Mutation, BRCA2 Mutation, Fanconi Anemia, Complementation Group D1
- Locations
-
- Weill Cornell Medicine New York, United States
- Duke University Durham, North Carolina, United States
- MD Anderson Cancer Center Houston, Texas, United States
Olaparib In Metastatic Breast Cancer
NCT03344965
- Conditions
- ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, San Francisco San Francisco, California, United States
- University of Chicago Chicago, Illinois, United States
- Indiana University Indianapolis, Indiana, United States